Key facts
- This page summarizes Patrick McCall's Form 4 filing for IN8BIO, INC. (INAB).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 08 Oct 2024, 16:15.
Patrick McCall - 04 Oct 2024 Form 4 Insider Report for IN8BIO, INC. (INAB)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- INAB
- Reported as of
- 04 Oct 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Oct 2024, 16:15:11 UTC
- Prior SEC filing
- 05 Sep 2024
- Next SEC filing
- 23 Dec 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jason Minio, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick McCall filed Form 4 for IN8BIO, INC. (INAB) on 08 Oct 2024.
Change
- Previous filing in this sequence was filed on 05 Sep 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INAB
transaction
Common Stock
Award
- Transaction value
- Shares
- +25,316
- Change %
- +95%
- Price
- Shares after
- 52,071
- Date
- 04 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INAB
transaction
Derivative
Series A Warrants (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -20,492
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,492
- Exercise price
- $1.25
- Footnotes
- F2, F3, F4
INAB
transaction
Derivative
Series A Warrants (right to buy)
Award
- Transaction value
- Shares
- +20,492
- Change %
- Price
- Shares after
- 20,492
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,492
- Exercise price
- $0.4500
- Footnotes
- F2, F3, F4
INAB
transaction
Derivative
Series C Warrants (right to buy)
Award
- Transaction value
- Shares
- +25,316
- Change %
- Price
- Shares after
- 25,316
- Date
- 04 Oct 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,316
- Exercise price
- $0.2700
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.
Footnote F2
The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.
Footnote F3
Fully vested and exercisable.
Footnote F4
The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.